This review covers the uses of fluorescence polarization and anisotropy for the investigation of bacterial penicillin binding proteins (PBPs), which are the targets of -lactam antibacterial drugs (penicillins, cephalosporins, carbapenems, and monobactams), and of the -lactamase enzymes that destroy these drugs and help to render bacterial pathogens resistant to them. Fluorescence polarization and anisotropy-based methods for quantitation of -lactam drugs are also reviewed. A particular emphasis is on methods for quantitative measurement of the interactions of -lactams and other inhibitors with PBPs and -lactamases.
Fluorescence polarization and anisotropy: a very brief introduction
Unlike fluorescence intensity measurements that use unpolarized light, fluorescence polarization and anisotropy measurements uses excitation light that has been passed through a polarizing filter. The polarized light preferentially excites those fluorophores with a certain orientation relative to the plane of the polarization. Because fluorophores in solution can tumble and change their orientation in the brief time between absorption and emission, the polarization of the emitted light can decrease from that of the exciting light. This effect can be quantified by making two intensity measurements of the emitted light through polarizers oriented parallel and perpendicular to the excitation polarizer. Larger molecules tumble more slowly than smaller molecules. Thus, binding of a low molecular weight fluorophore to a macromolecule often results in higher polarization of the emitted light than for the free fluorophore due to reduced mobility of the fluorophore.
Polarization and anisotropy are related measurements that differ only in the way the calculation is made from the two emission measurements. If Ipara and Iperp represent the emission intensities measured through the polarizers oriented parallel and perpendicular to the excitation polarizer, then Polarization (P) = (Ipara -Iperp)/(Ipara + Iperp) and Anisotropy (r) = (Ipara -Iperp)/(Ipara + 2Iperp)
The quantity (Ipara + 2Iperp) is the total fluorescence.
Anisotropy is preferable to polarization, in some cases, because the anisotropies of a mixture of substances with different fluorescence intensities can be added together in a simple way, which is not true of their polarizations.
Polarization and anisotropy measurements can be made with polarizer-equipped spectrofluorometers or fluorescence plate readers. For time-based measurements, it is desirable to measure Ipara and Iperp simultaneously. This requires two separate emission detectors.
In many applications, only the change in anisotropy or polarization due to a treatment, such as the addition of a macromolecular binding partner, is of interest. If the true value of anisotropy or polarization is required, however, then it is necessary to adjust for any difference in sensitivity between the measurements of Ipara and Iperp due to the instrumentation. A correction factor for the sensitivity difference is called the G-factor (G). With the G-factor correction, the expression for anisotropy is r = (Ipara -GIperp)/(Ipara + 2GIperp) When using anisotropy to measure a dissociation constant (Kd) for a fluorophore binding to a macromolecule, any difference in the fluorescence intensities of the free and bound fluorophore introduces an error in the Kd measurement. If the intensity of the bound fluorophore (Ibound) is lower than that of the free fluorophore (Ifree), the measured Kd (Kd,apparent)will appear higher than the true value, and if the intensity of the bound fluorophore is higher than that of the free fluorophore, the Kd will appear lower than the true value, unless a correction is introduced, as follows.
See [93] for a detailed theoretical treatment of fluorescence polarization and anisotropy.
Antibacterial drugs and their fluorescent analogs
Antibacterial drugs containing a -lactam ring, including penicillin, cephalosporins, carbapenems, and monobactams [1], have been a mainstay of antibacterial therapy for over 60 years. These drugs work by reacting covalently with a catalytic serine residue in the transpeptidase (TP) domain of one or more of the high molecular weight penicillin binding proteins (PBPs) found on the external (Gram positives) or periplasmic (Gram negatives) surface of the cytoplasmic membrane of bacteria [2] . The TP domain is responsible for forming crosslinks within the peptidoglycan cell wall that surrounds the cytoplasmic membrane, protecting the bacteria from osmotic lysis. Inhibition of TP domains by -lactams results in disturbances in cellular shape and ultimately to cell lysis. Since no such functionality exists in mammals, -lactams are highly selective for bacteria, largely avoiding mechanism-based toxicity, although allergic reactions occur in some patients.
A key mechanism by which bacteria have become resistant to -lactam drugs is by expression of -lactamase enzymes that destroy the essential -lactam [3] . Three of the 4 classes (A, C, and D) of -lactamases have an active site serine residue that, like PBPs, reacts covalently with -lactams. Unlike PBPs, however, -lactamases rapidly cleave and release the covalent acyl-enzyme intermediate. The fourth class (B) of -lactamases consists of the metallo--lactamases, which have a metal ion in the active site. The activity of some of the serine -lactamases can be inhibited by -lactam compounds that have low rates of hydrolysis by the enzymes [4] .
Investigations of the reactivities of PBPs and -lactamases with -lactams, and other measurements, have been aided by the availability of fluorescent analogs of -lactams. An early example of the preparation of a fluorescent -lactam was reported by Dandliker et al [5, 6] . A fluorescein derivative of penicillin was used as a hapten in an early use of fluorescence polarization immunoassay (FPIA) to detect anti-penicillin antibodies in human sera, which are correlated to an allergic response to penicillin. Thus the first reported use of a fluorescent -lactam analog was used for fluorescence polarization-based measurements. FPIA for aminoglycoside antibacterial drug measurement was also used to test for reactivity of -lactams with aminoglycosides when administered together to patients [7] [8] [9] . Testing for the presence in blood of anti-penicillin IgE antibodies as an indicator of penicillin allergy in clinical practice has focused on other techniques, however, including a fluorometric enzyme immunoassay (FEIA), which uses a fluorescence intensity measurement rather than fluorescence polarization [10] [11] [12] .
Several other fluorescent and fluorogenic -lactam analogs have been synthesized, including penicillin, cephalosporin, and carbapenem derivatives . In addition, a fluorescent boronic acid-based probe for PBPs and -lactamases was reported [37] . BODIPY FL penicillin (BOCILLIN TM ) [16, 38] , and the fluorogenic -lactamase cephalosporin substrates CCF2 [15] and Fluorocillin [29] are available commercially. Additionally, CCF2 and the related CCF4 are available as cell-permeant esters for use with -lactamase gene expression reporters. In addition to fluorescent -lactam analogs, intrinsic tryptophan fluorescence [39] [40] [41] [42] [43] [44] [45] [46] [47] and covalent extrinsic non--lactam fluorophores [14, 43, 48, 49] have been used in studies of PBPs and -lactamases.
Fluorescent -lactam analogs, intrinsic tryptophan fluorescence, and extrinsic non--lactam fluorophores have been used for many purposes. This review will focus on the experimental investigation of -lactams, -lactamases and PBPs using fluorescence polarization or anisotropy (Table 1) .
Experimental investigations
A commonly reported fluorescence intensity-based technique is to react a bacterial membrane preparation containing native PBPs or a purified PBP with BOCILLIN or other fluorescent -lactam, separate the products by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and use fluorescence imaging to detect the labeled PBPs. This technique has several uses. It can be used simply to detect, and in some cases quantify, the native PBPs in the bacterial membranes after separating the PBPs on the basis of the differences between their molecular weights [38, [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] . Further, by incubating the membranes with a PBPreactive compound or competitive inhibitor of the BOCILLIN reaction prior to the addition of BOCILLIN, this technique can be used to differentiate between PBPs with respect to their reactivities with or affinities for the compound [16, 60, 61, [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] . In some cases, quantitative measurements of the potencies or affinities of the compounds have been obtained. BOCILLIN fluorescence labeling of PBPs in membranes has supplanted radioactive penicillin labeling and autoradiography for gel-based PBP detection, the method pioneered by Spratt and Pardee [79] .
With purified PBPs, it is possible to use the SDS-PAGE technique to obtain detailed affinity or kinetic measurements of the reaction of BOCILLIN and competitors [54, 71, 74, [80] [81] [82] [83] [84] . This technique has also been used with mutant -lactamases that have greatly reduced rates of acyl-enzyme hydrolysis, which allows the acyl-enzyme intermediate to accumulate to a detectable level [85] [86] . For these investigations with purified proteins, SDS-PAGE or other separation step [13, 14, 87] is necessitated by the lack of a substantial difference between the fluorescence intensities of free and bound fluorescent -lactam. With the fortuitous placement of one or more intrinsically fluorescent amino acid residue(s), real-time kinetic measurements of -lactam binding to a purified PBP have been made using intrinsic fluorescence quenching without a separation step [14, [39] [40] [41] 44, 45] . Rapid mixing techniques have been used to observe the kinetics of the reaction between -lactamases and fluorescent -lactams by monitoring changes in the fluorescence intensity of an environmentally sensitive fluorophore [25,26]. As will be described below, measurement of the fluorescence anisotropy of a fluorescent -lactam analog also allows real-time kinetic measurements to be made for purified, soluble proteins without a separation step.
End-point fluorescence polarization or anisotropy-based measurement of the reaction between a fluorescent -lactam, BOCILLIN FL, and a purified PBP was first reported by Zhao et al [38] with Streptococcus pneumoniae PBP2x. Penicillin G competed with the reaction. These measurements were made in a 96-well format.
Several years passed before the next publication describing the use of fluorescence anisotropy to test for competitive binding to a purified PBP. In this case, however, it was the transglycosylase (TG) domain rather than the transpeptidase domain that was the target, and the fluorescent ligand was a fluorescein derivative of the glycolipid antibiotic moenomycin [88] . The TG domain catalyzes polymerization of the polysaccharide backbone of peptidoglycan. The high-throughput fluorescence anisotropy-based competitive binding assay was used to screen 57,000 small molecules in 384-well plates for inhibition of fluoresceinmoenomycin binding to Helicobacter pylori PBP1a. Since moeonomycin is a noncovalent inhibitor of the TG domain, this screen was done under equilibrium binding conditions.
The last few years have seen several more examples of the use of fluorescence anisotropy or polarization to measure competitor binding to the TP domain of PBPs. Fedarovich et al [89] described a high-throughput fluorescence polarization-based assay for inhibition of the reaction of BOCILLIN FL with PBP2 from Neisseria gonorrhoeae. The assay was used to screen a 50,000-compound library in 384-well plates. Inglis et al [37] prepared a fluorescein derivative of a boronic acid-based inhibitor of PBPs and -lactamases that was used to measure the potencies versus 3 PBPs and a -lactamase of -lactams and boronic acids in competitive fluorescence polarization-based binding assays in 96-well plates.
The assays described by Fedarovich et al [89] and Inglis et al [37] did not take into account the time-dependent potencies of -lactam-based inhibitors of PBPs, including BOCILLIN FL, which arises because of the covalent, essentially irreversible reaction. (Boronic acids, though forming a dative covalent bond, are reversible inhibitors). As a result, the potencies of -lactams increase with the time of exposure of the PBPs to the compounds [90] .
Shapiro et al [90, 91] made continuous fluorescence anisotropy-based measurements of the reaction of BOCILLIN FL with purified, soluble constructs of PBPs in the presence of various concentrations of other -lactams and fit the data to a competitive kinetic model to obtain PBP acylation rate constants for BOCILLIN FL and other -lactams. These rate constants are a reaction time-independent potency measurement. These measurements were performed in 384-well plates and had sufficient throughput to support routine compound testing in a drug discovery environment. A limitation of this method is the requirement for watersoluble PBP constructs, as opposed to detergent-solubilized membrane proteins, because BOCILLIN FL partitions into detergent micelles, resulting in high basal fluorescence anisotropy.
The fluorescence anisotropy of BOCILLIN FL does not change significantly when it is hydrolyzed by -lactamases, so BOCILLIN FL fluorescence anisotropy-based kinetic measurements with these enzymes are restricted to mutant enzymes having greatly reduced rates of hydrolysis of the acyl-enzyme intermediate. Buchman et al [86] and Shapiro et al [90] made BOCILLIN FL fluorescence anisotropy-based kinetic measurements of the rates of acylation and deacylation of such mutant OXA-1 and OXA-10 -lactamases, respectively. Extending this type of measurement to another class of -lactam, June et al [22] used a fluorescein derivative of meropenem, a carbapenem, to perform fluorescence-based kinetic measurements of acylation of soluble constructs of PBP3 and -lactam sensor protein BlaR1. Additionally, June et al measured acylation and deacylation rates of wild-type AmpC-lactamase, an enzyme that has a very low rate of carbapenem hydrolysis.
Kinetic measurements of fluorescence anisotropy or polarization require simultaneous measurement of parallel and perpendicular emission. A cuvette-based spectrofluorometer with T-format detectors was used by Buchman et al [86] and June et al [22] , whereas a plate reader with dual emission detectors was used by Shapiro et al [90, 91] . The latter instrumentation enables many reactions to be monitored at the same time but sacrifices detection of the first half-minute or so of the reactions while reagents are dispensed and mixed and the plate is inserted into the plate reader.
In addition to fluorescence anisotropy-and polarization-based measurements of the association of fluorescent inhibitor analogs with PBPs and -lactamases, a few studies have used intrinsic tryptophan fluorescence and covalently attached, non--lactam fluorescent dyes to study these proteins. Intrinsic tryptophan fluorescence polarization measurements played a role in the biophysical characterization by absorbance, circular dichroism, and fluorescence spectroscopies of a -lactamase from Bacillus licheniformis by Risso et al [42] . Fluorescence anisotropy measurements as a probe of rotational dynamics contributed to the investigation of the protein-protein interaction between TEM -lactamase and -lactamase inhibitor protein (BLIP) by Kuttner et al [43] . This study used Alexa488-labeled BLIP.
As part of an investigation of the mechanism of -lactam resistance of methicillinresistant Staphylococcus aureus (MRSA), Blázquez et al [92] used the fluorescence anisotropy of fluorescently labelled DNA consisting of the operator regions of the mec and bla genes to measure the binding to the operators of the MecI and BlaI repressor proteins.
Bergeron et al [20] used the increase in the fluorescence anisotropy of a fluorescein derivative of 6-aminopenicillanic acid (6-APA) to measure the affinity of this compound for a chaperonin protein of Methanocaldococcus jannaschii and localize its binding site. 6-APA is an inhibitor of the protein refolding activity of the chaperonin.
Conclusion
The medical importance of -lactam drugs today and in the foreseeable future in the treatment of bacterial infections, and the necessity to inhibit the -lactamases that can limit their effectiveness, dictate that scientists in academia, government laboratories, and the pharmaceutical industry will continue to study PBPs, -lactamases, and their interactions with -lactams and other inhibitors. Fluorescence techniques, including polarization and anisotropy, have been important tools for these investigations for decades. The commercial availability of the fluorescent penicillin analog BOCILLIN FL has aided in the application of these techniques, and it is to be hoped that fluorescent analogs of other classes of -lactams, which have been described in the literature, will also become commercially available. Fluorescein-labeled boronic acid [37] 
